Evidence map›Paper›PMID 39747176›Full record

ArticleScientific reports2025

The revised colorectal cancer screening guideline and screening burden at community health centers.

Adjoa Anyane-Yeboa, Helen Bermudez, Michelle Fredericks, Nathan Yoguez, Lynn Ibekwe-Agunanna, James Daly, Emily Hildebrant, Madhur Kuckreja, Rachel Hindin, Leslie Pelton-Cairns and 4 more

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Colorectal Cancer Test Completion among Adults Aged 45 to 75 in an Integrated Healthcare System: A Retrospective Analysis.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2026
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Adjoa Anyane-YeboaDivision of Gastroenterology, Massachusetts General Hospital, Boston, MA, USA. aanyane-yeboa@mgh.harvard.edu.
Helen BermudezDivision of General Internal Medicine, Massachusetts General Hospital, Boston, MA, USA.
Michelle FredericksDana-Farber Cancer Institute, Boston, MA, USA.
Nathan YoguezDivision of Gastroenterology, Massachusetts General Hospital, Boston, MA, USA.
Lynn Ibekwe-AgunannaUT Southwestern Medical Center, Dallas, TX, USA.
James DalyHarvard T.H. Chan School of Public Health, Boston, MA, USA.
Emily HildebrantDuffy Health Center, Hyannis, MA, USA.
Madhur KuckrejaBrockton Neighborhood Health Center, Brockton, MA, USA.
Rachel HindinCodman Square Health Center, Dorchester, MA, USA.
Leslie Pelton-CairnsMassachusetts League of Community Health Centers, Boston, MA, USA.
Leslie Salas KarnesMassachusetts League of Community Health Centers, Boston, MA, USA.
Gina R KruseDepartment of Medicine, University of Colorado Denver, Denver, CO, USA.
Daniel A GundersenRutgers Institute for Nicotine and Tobacco Studies, New Brunswick, NJ, USA.
Karen M EmmonsHarvard T.H. Chan School of Public Health, Boston, MA, USA.

Funding

UT Southwestern Medical Center Simmons Comprehensive Cancer CenterP30CA142543 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI Kathryn Ann O'Donnell · 2010 to 2026
$53.7M
The Implementation Science Center for Cancer Control Equity - Research ProgramP50CA244433 · NCI · HARVARD SCHOOL OF PUBLIC HEALTH · PI EMMONS, KAREN M. · 2019 to 2023
$12.5M
The Harvard Chan Education Program in Cancer Prevention and ControlT32CA057711 · NCI · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI Karen M. Emmons, ANNE LINDSAY FRAZIER · 2019 to 2026
$3.3M
Diversity Supplement to NCI P50CA44433NCI NIH HHS L60 CA274795NCI NIH HHS P30 CA142543NCI NIH HHS P50 CA244433NCI NIH HHS T32 CA057711NIH/NCI P50CA44433
6 · The paper itself

Abstract

Colorectal cancer (CRC) is the third most common cancer among men and women combined, and the second leading cause of cancer death in the US. The revised USPSTF CRC screening recommendations increased CRC screening needs across health systems, which may create particular challenges for community health centers (CHCs) given their resource constraints. The objective of our study is to assess CRC screening rates across 10 CHCs in Massachusetts and estimate the additional increase in the number of average-risk screening-eligible individuals after the revision in guidelines. CRC screening was defined as being up to date vs. not up to date based on any of the approved screening modalities in the appropriate time frame. Our outcome of interest was CRC screening by age group and the percentage increase in screenings needed to screen individuals 45 to 49 across our partner CHCs after the revision in guidelines. Our analysis included 70,808 individuals aged 45 to 75. The overall CRC screening rate was 35.9% after the USPSTF guideline revision. Screening rates were lowest in those aged 45 to 49 at 9.6%, and highest in those over age 55 at 47.0%. There was a 22.9% increase in additional screenings needed after USPSTF guideline revision. The revised USPSTF guidelines increased screening needs by about 23% without additional funding for CHCs for which demand already outstrips staffing and clinical care resources. Future studies should include cost analyses of screening the population 45 to 49 and identify effective strategies that are low burden and do not add to the workload of CHC providers to improve screening at CHCs.

Indexed as

Colorectal NeoplasmsCommunity Health CentersEarly Detection of CancerAgedFemaleHumansMaleMassachusettsMass ScreeningMiddle AgedPractice Guidelines as TopicColorectal cancer screeningCommunity health centersUSPSTF guidelines

Identifiers

PMID39747176
PMCPMC11696018

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.